Andrei Iancu, David Kappos, and Paul R. Michel, Author at Council for Innovation Promotion (C4IP)

Lawmakers want to weaken U.S. patents that made new anti-COVID pills possible. We should do everything to protect them

Op-Ed / By Andrei Iancu, David Kappos, and Paul R. Michel

Andrei Iancu, David Kappos, and Paul R. Michel https://fortune.com/2022/03/04/new-covid-pills-patents-pfizer-merk-ip-pandemic-pharma-health-iancu-kappos-michel/ Fortune

Lawmakers want to weaken U.S. patents that made new anti-COVID pills possible. We should do everything to protect them Read More »

Big Tech is abusing the U.S. patent challenge system

Op-Ed / By Paul R. Michel

Paul R. Michel https://news.trust.org/item/20220218102516-a1p08 Reuters

Big Tech is abusing the U.S. patent challenge system Read More »

Thank You, Senator Tillis, for Recognizing the Need for Evidence-Based Policymaking in Patent Law

Op-Ed / By Adam Mossoff

Adam Mossoff Thank You, Senator Tillis, for Recognizing the Need for Evidence-Based Policymaking in Patent Law IPWatchdog

Thank You, Senator Tillis, for Recognizing the Need for Evidence-Based Policymaking in Patent Law Read More »

The Supreme Court is partly to blame for the Covid-19 test kit shortage

Op-Ed / By Paul R. Michel

Paul R. Michel The Supreme Court is partly to blame for the Covid-19 test kit shortage STAT (Also published by the Boston Globe)

The Supreme Court is partly to blame for the Covid-19 test kit shortage Read More »

Can We Please Get Serious About Patents and Drug Pricing?

Op-Ed / By Barney Cassidy

Barney Cassidy https://www.realclearpolicy.com/articles/2022/01/06/can_we_please_get_serious_about_patents_and_drug_pricing_810732.html RealClearPolicy

Can We Please Get Serious About Patents and Drug Pricing? Read More »

World leaders should acknowledge that IP protections facilitate vaccine access

Op-Ed / By Andrei Iancu

Andrei Iancu https://fortune.com/2021/12/24/ip-protections-facilitate-vaccine-access-world-leaders-covid-pandemic-intellectual-property-biden-international-pharma-health-andrei-iancu/ Fortune

World leaders should acknowledge that IP protections facilitate vaccine access Read More »

Why does the FDA want to stop improving medicines via patent ‘areas of concern’?

Op-Ed / By Andrei Iancu

Andrei Iancu Why does the FDA want to stop improving medicines via patent ‘areas of concern’? STAT

Why does the FDA want to stop improving medicines via patent ‘areas of concern’? Read More »

Time to Fight Back Against Big Tech’s IP Assault

Op-Ed / By Paul R. Michel

Paul R. Michel https://www.newsweek.com/time-fight-back-against-big-techs-ip-assault-opinion-1641267 Newsweek

Time to Fight Back Against Big Tech’s IP Assault Read More »

Biden is trying to undermine America’s world-leading IP protections

Op-Ed / By Andrei Iancu

Andrei Iancu https://www.washingtontimes.com/news/2021/aug/11/biden-is-trying-to-undermine-americas-world-leadin/ Washington Times

Biden is trying to undermine America’s world-leading IP protections Read More »

Federal Tech, Trade Bill Needs IP Owner Transparency Tweaks

Op-Ed / By David Kappos and Paul R. Michel

David Kappos and Paul R. Michel https://www.law360.com/articles/1399081/federal-tech-trade-bill-needs-ip-owner-transparency-tweaks Law360

Federal Tech, Trade Bill Needs IP Owner Transparency Tweaks Read More »

Waiving Covid-19 vaccine patents won’t get shots in arms faster. It slows down new vaccines.

Op-Ed / By David Kappos and Paul R. Michel

David Kappos and Paul R. Michel https://www.nbcnews.com/think/opinion/waiving-covid-19-vaccine-patents-won-t-get-shots-arms-ncna1268099 NBC Think

Waiving Covid-19 vaccine patents won’t get shots in arms faster. It slows down new vaccines. Read More »

No evidence that patents slow access to vaccines

Op-Ed / By Andrei Iancu

Andrei Iancu No evidence that patents slow access to vaccines STAT

No evidence that patents slow access to vaccines Read More »

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Andrei Iancu, David Kappos, and Paul R. Michel

Lawmakers want to weaken U.S. patents that made new anti-COVID pills possible. We should do everything to protect them

Big Tech is abusing the U.S. patent challenge system

Thank You, Senator Tillis, for Recognizing the Need for Evidence-Based Policymaking in Patent Law

The Supreme Court is partly to blame for the Covid-19 test kit shortage

Can We Please Get Serious About Patents and Drug Pricing?

World leaders should acknowledge that IP protections facilitate vaccine access

Why does the FDA want to stop improving medicines via patent ‘areas of concern’?

Time to Fight Back Against Big Tech’s IP Assault

Biden is trying to undermine America’s world-leading IP protections

Federal Tech, Trade Bill Needs IP Owner Transparency Tweaks

Waiving Covid-19 vaccine patents won’t get shots in arms faster. It slows down new vaccines.

No evidence that patents slow access to vaccines

Contact

Menu